Rhumbline Advisers Increases Position in Transcat, Inc. (NASDAQ:TRNS)

Rhumbline Advisers boosted its position in Transcat, Inc. (NASDAQ:TRNS) by 6.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,110 shares of the scientific and technical instruments company’s stock after buying an additional 762 shares during the period. Rhumbline Advisers owned approximately 0.14% of Transcat worth $976,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in TRNS. Jones Financial Companies Lllp grew its holdings in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after acquiring an additional 309 shares during the period. Aquatic Capital Management LLC grew its stake in Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock worth $122,000 after acquiring an additional 1,052 shares during the period. Morgan Dempsey Capital Management LLC acquired a new position in Transcat in the fourth quarter valued at $143,000. GAMMA Investing LLC raised its stake in Transcat by 10,137.5% during the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company’s stock worth $122,000 after purchasing an additional 1,622 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new stake in Transcat during the fourth quarter worth about $190,000. 98.34% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

TRNS has been the topic of several research reports. HC Wainwright restated a “buy” rating and issued a $116.00 price target (up previously from $106.00) on shares of Transcat in a report on Wednesday, May 21st. Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a research note on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $114.00.

Transcat Price Performance

TRNS opened at $81.09 on Friday. The company has a market capitalization of $755.76 million, a P/E ratio of 51.98 and a beta of 0.75. The company has a 50-day moving average of $82.74 and a 200-day moving average of $86.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.87 and a current ratio of 2.29. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $147.12.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.02). The business had revenue of $77.13 million for the quarter, compared to analyst estimates of $76.40 million. Transcat had a return on equity of 6.47% and a net margin of 5.21%. Transcat’s revenue for the quarter was up 8.8% compared to the same quarter last year. Equities analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.